About Contact Us Careers
Sign In

Female Stress Urinary Incontinence Treatment Devices Market - Top Companies and Manufacturers

  • Report ID: 4376
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Companies Dominating the Female Stress Urinary Incontinence Treatment Devices Landscape

    • Boston Scientific Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Johnson & Johnson Services, Inc.
    • Becton, Dickinson and Company
    • Coloplast Corp.
    • CooperSurgical, Inc.
    • MedGyn Products, Inc.
    • Caldera Medical, Inc
    • FEG Textiltechnik mbH
    • Medical Device Business Services, Inc.
    • Renovia Inc.
Browse Key Market Insights with Data Illustration:

In the News

  • Renovia Inc., a leading company in the field of developing digital therapeutics for female pelvic floor disorders informed that Leva, a pelvic health system to treat women in urinary continence received acceptance from researchers supporting its value. It is stated that Leva can provide UI symptom improvement for 12 months and creates real-world data to increase its effectiveness.

  • Boston Scientific Corporation declared that Solyx, a single incision sling system succeeded in the treatment of women with stress urinary incontinence. It is designed to decrease dissection and provide a less complicated procedure.


Author Credits:  Radhika Pawar


  • Report ID: 4376
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of female stress urinary incontinence treatment devices is assessed at USD 745.79 Million.

The female stress urinary incontinence treatment devices market size was over USD 704.24 Million in 2023 and is likely to reach USD 1.48 Billion by the end of 2036, growing at around 5.9% CAGR during the forecast period i.e., between 2024-2036. Increase in instances of urinary incontinence and growing incidence of urinary incontinence due to menopause are the major factors driving the market growth.

North America is poised to account for majority industry share by 2036, attributed to well-established healthcare infrastructure boosted by investment and growing R&D of drugs and medications.

Boston Scientific Corporation, Johnson & Johnson Services, Inc., Becton, Dickinson and Company, Coloplast Corp., CooperSurgical, Inc., MedGyn Products, Inc., Caldera Medical, Inc, FEG Textiltechnik mbH, Medical Device Business Services, Inc., Renovia Inc.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample